Hunan Warrant Pharmaceutical Co.,Ltd
SHH: 688799.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ben Dong Huang
- Employees
- 1,238
- Headquarters
- Changsha, China
- IPO year
- 2021
- Market cap
- CN¥8.1B
- Website
- https://www.warrant.com.cn
Loading 688799…
Loading profile data…Frequently asked questions about 688799
What does Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) do?
Hunan Warrant Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products. It offers medicines in the areas of immune and kidney, obstetrics and gynecology, cardiovascular, digestion, and other diseases; and anti-infection medicines. The company was founded in 2001 and is based in Changsha, China.
Where does 688799.SS trade?
Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) trades on the Shanghai Stock Exchange.
What sector is 688799.SS in?
Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hunan Warrant Pharmaceutical Co.,Ltd?
Ben Dong Huang is the chief executive officer of Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS).
Where is Hunan Warrant Pharmaceutical Co.,Ltd headquartered?
Hunan Warrant Pharmaceutical Co.,Ltd is headquartered in China.
Does 688799.SS pay a dividend?
Yes — Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) paid a trailing twelve-month dividend of CNY 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688799.SS go public?
Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) completed its initial public offering in 2021.